Characterization of Calu-3 cell monolayers as a model of bronchial epithelial transport: Organic cation interaction studies

Journal of Drug Targeting

Volumn 21, Issue 1, 2013, Pages 97-106

  MacDonald, Chris ^a   Shao, Di ^a   Oli, Angus ^b   Agu, Remigius U ^a  

^a DALHOUSIE UNIVERSITY   (Canada)

^b NNAMDI AZIKIWE UNIVERSITY   (Nigeria)

Author keywords

Carnitine organic cation transporter (OCTN1, OCTN2); Organic cation transporters (OCT1 3); Pulmonary epithelium

Indexed keywords

CARNITINE; CATION; CORTICOSTERONE; FLUORESCENT DYE; VERAPAMIL;

ARTICLE; BRONCHUS MUCOSA; CATION TRANSPORT; CELL MEMBRANE PERMEABILITY; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG INHIBITION; DRUG UPTAKE; FLUORESCENCE MICROSCOPY; IMMUNOHISTOCHEMISTRY; MOLECULAR BIOLOGY; MONOLAYER CULTURE; PH; POLYMERASE CHAIN REACTION; PRIORITY JOURNAL; QUANTITATIVE ANALYSIS; TEMPERATURE DEPENDENCE; TISSUE CULTURE;

BIOLOGICAL TRANSPORT, ACTIVE; BRONCHI; CARNITINE; CELL LINE; CORTICOSTERONE; EPITHELIAL CELLS; FLUORESCENT DYES; GENE EXPRESSION REGULATION; HUMANS; HYDROGEN-ION CONCENTRATION; INHIBITORY CONCENTRATION 50; METHYLAMINES; MICROSCOPY, FLUORESCENCE; MODELS, BIOLOGICAL; ORGANIC CATION TRANSPORT PROTEINS; POLYMERASE CHAIN REACTION; PYRIDINIUM COMPOUNDS; TEMPERATURE; VERAPAMIL;

EID: 84872042131     PISSN: 1061186X     EISSN: 10292330     Source Type: Journal    
DOI: 10.3109/1061186X.2012.731068     Document Type: Article

References (32)

1. Angelis ID, Turco L. (2011). Caco-2 cells as a model for intestinal absorption. Curr Protoc Toxicol, 47, 20.6.1-20.6.15.
2. Bosquillon C. (2010). Drug transporters in the lung-do they play a role in the biopharmaceutics of inhaled drugs? J Pharm Sci, 99, 2240-2255.
3. Ehrhardt C, Kneuer C, Bies C, Lehr CM, Kim KJ, Bakowsky U. (2005). Salbutamol is actively absorbed across human bronchial epithelial cell layers. Pulm Pharmacol Ter, 18, 165-170.
4. Fernandes CA, Vanbever R. (2009). Preclinical models for pulmonary drug delivery. Expert Opin Drug Deliv, 6, 1231-1245.
5. Florea BI, van der Sandt IC, Schrier SM, Kooiman K, Deryckere K, de Boer AG, Junginger HE, Borchard G. (2001). Evidence of P-glycoprotein mediated apical to basolateral transport of funisolide in human broncho-tracheal epithelial cells (Calu-3). Br J Pharmacol, 134, 1555-1563.
6. Florea BI, Cassara ML, Junginger HE, Borchard G. (2003). Drug transport and metabolism characteristics of the human airway epithelial cell line Calu-3. J Control Release, 87, 131-138.
7. Gnadt M, Trammer B, Freiwald M, Kardziev B, Bayliss MK, Edwards CD, Schmidt M, Friedel G, Högger P. (2012). Methacholine delays pulmonary absorption of inhaled β(2)-agonists due to competition for organic cation/carnitine transporters. Pulm Pharmacol Ter, 25, 124-134.
8. Grigat S, Harlfnger S, Pal S, Striebinger R, Golz S, Geerts A, Lazar A, Schömig E, Gründemann D. (2007). Probing the substrate specifcity of the ergothioneine transporter with methimazole, hercynine, and organic cations. Biochem Pharmacol, 74, 309-316.
9. Grigat S, Fork C, Bach M, Golz S, Geerts A, Schömig E, Gründemann D. (2009). The carnitine transporter SLC22A5 is not a general drug transporter, but it efciently translocates mildronate. Drug Metab Dispos, 37, 330-337.
10. Hamilton KO, Backstrom G, Yazdanian MA, Audus KL. (2001). P-glycoprotein efux pump expression and activity in Calu-3 cells. J Pharm Sci, 90, 647-658.
11. Haycock JW. (2011). 3D cell culture: a review of current approaches and techniques. Methods Mol Biol, 695, 1-15.
12. Horvath G, Mendes ES, Schmid N, Schmid A, Conner GE, Salathe M, Wanner A. (2007a). The efect of corticosteroids on the disposal of long-acting beta2-agonists by airway smooth muscle cells. J Allergy Clin Immunol, 120, 1103-1109.
13. Horvath G, Schmid N, Fragoso MA, Schmid A, Conner GE, Salathe M, Wanner A. (2007b). Epithelial organic cation transporters ensure pH-dependent drug absorption in the airway. Am J Respir Cell Mol Biol, 36, 53-60.
14. Inazu M, Takeda H, Matsumiya T. (2005). Molecular and functional characterization of an Na+-independent choline transporter in rat astrocytes. J Neurochem, 94, 1427-1437.
15. Koepsell H, Lips K, Volk C. (2007). Polyspecifc organic cation transporters: structure, function, physiological roles, and biopharmaceutical implications. Pharm Res, 24, 1227-1251.
16. Kummer W, Lips KS, Pfeil U. (2008). The epithelial cholinergic system of the airways. Histochem Cell Biol, 130, 219-234.
17. Lips KS, Volk C, Schmitt BM, Pfeil U, Arndt P, Miska D, Ermert L, Kummer W, Koepsell H. (2005). Polyspecifc cation transporters mediate luminal release of acetylcholine from bronchial epithelium. Am J Respir Cell Mol Biol, 33, 79-88.
18. Martel F, Gründemann D, Calhau C, Schömig E. (2001). Apical uptake of organic cations by human intestinal Caco-2 cells: putative involvement of ASF transporters. Naunyn Schmiedebergs Arch Pharmacol, 363, 40-49.
19. Mukherjee M, Pritchard DI, Bosquillon C. (2012). Evaluation of air-interfaced Calu-3 cell layers for investigation of inhaled drug interactions with organic cation transporters in vitro. Int J Pharm, 426, 7-14.
20. Nakamura T, Nakanishi T, Haruta T, Shirasaka Y, Keogh JP, Tamai I. (2010). Transport of ipratropium, an anti-chronic obstructive pulmonary disease drug, is mediated by organic cation/carnitine transporters in human bronchial epithelial cells: implications for carrier-mediated pulmonary absorption. Mol Pharm, 7, 187-195.
21. Ohashi R, Tamai I, Yabuuchi H, Nezu JI, Oku A, Sai Y, Shimane M, Tsuji A. (1999). Na(+)-dependent carnitine transport by organic cation transporter (OCTN2): its pharmacological and toxicological relevance. J Pharmacol Exp Ter, 291, 778-784.
22. Paturi DK, Kwatra D, Ananthula HK, Pal D, Mitra AK. (2010). Identifcation and functional characterization of breast cancer resistance protein in human bronchial epithelial cells (Calu-3). Int J Pharm, 384, 32-38.
23. Reichl S, Kölln C, Hahne M, Verstraelen J. (2011). In vitro cell culture models to study the corneal drug absorption. Expert Opin Drug Metab Toxicol, 7, 559-578.
24. Salomon JJ, Ehrhardt C. (2012). Organic cation transporters in the blood-air barrier: expression and implications for pulmonary drug delivery. Ter Deliv, 3, 735-747.
25. Salomon JJ, Endter S, Tachon G, Falson F, Buckley ST, Ehrhardt C. (2012). Transport of the fuorescent organic cation 4-(4-(dimethylamino) styryl)-N-methylpyridinium iodide (ASP+) in human respiratory epithelial cells. Eur J Pharm Biopharm, 81, 351-359.
26. Schild L, Roch-Ramel F, Diezi J. (2007). Renal transport of organic ions and uric acid. In: Schrier RW, ed. Diseases of the Kidney and Urinary Tract. Philadelphia: Lippincott Williams and Wilkins (LWW), 218-233.
27. Sporty JL, Horálková L, Ehrhardt C. (2008). In vitro cell culture models for the assessment of pulmonary drug disposition. Expert Opin Drug Metab Toxicol, 4, 333-345.
28. Steimer A, Haltner E, Lehr CM. (2005). Cell culture models of the respiratory tract relevant to pulmonary drug delivery. J Aerosol Med, 18, 137-182.
29. Sun D, Yu LX, Hussain MA, Wall DA, Smith RL, Amidon GL. (2004). In vitro testing of drug absorption for drug 'developability' assessment: forming an interface between in vitro preclinical data and clinical outcome. Curr Opin Drug Discov Devel, 7, 75-85.
30. Vllasaliu D, Fowler R, Garnett M, Eaton M, Stolnik S. (2011). Barrier characteristics of epithelial cultures modelling the airway and intestinal mucosa: a comparison. Biochem Biophys Res Commun, 415, 579-585.
31. Yabuuchi H, Tamai I, Nezu J, Sakamoto K, Oku A, Shimane M, Sai Y, Tsuji A. (1999). Novel membrane transporter OCTN1 mediates multispecifc, bidirectional, and pH-dependent transport of organic cations. J Pharmacol Exp Ter, 289, 768-773.
32. Zhu Y, Chidekel A, Shafer TH. (2010). Cultured human airway epithelial cells (calu-3): a model of human respiratory function, structure, and infammatory responses. Crit Care Res Pract, 2010.